Lymphocyte subtypes in relapsing–remitting multiple sclerosis patients treated with dimethyl fumarate

BACKGROUND: Recent data suggest that lymphopenia is more prevalent than reported in relapsing–remitting multiple sclerosis (RRMS) patients taking dimethyl fumarate (DMF). OBJECTIVE: The objective of this study was to investigate the effect of DMF on lymphocyte subtypes in RRMS patients with and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves, C, Ganguly, R, Ceresia, C, Camac, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408504/
https://www.ncbi.nlm.nih.gov/pubmed/28607757
http://dx.doi.org/10.1177/2055217317702933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408504/
https://www.ncbi.nlm.nih.gov/pubmed/28607757
http://dx.doi.org/10.1177/2055217317702933

Ejemplares similares